{
  "id": "5b8d57704ac400ca",
  "title": "US oral GLP - 1 first as Novo Nordisk launches Wegovy pill",
  "description": "20260106T170000Z",
  "content": "",
  "source": "europeanpharmaceuticalreview.com",
  "source_url": "https://www.europeanpharmaceuticalreview.com/news/269956/oral-glp-1-obesity-novo-nordisk-wegovy-pill/",
  "published_at": "20260106T170000Z",
  "fetched_at": "2026-01-07T00:22:40.638561+00:00",
  "category": "health_biotech",
  "subcategory": null,
  "keywords": [],
  "location": "United Kingdom",
  "raw_data": {
    "url": "https://www.europeanpharmaceuticalreview.com/news/269956/oral-glp-1-obesity-novo-nordisk-wegovy-pill/",
    "url_mobile": "",
    "title": "US oral GLP - 1 first as Novo Nordisk launches Wegovy pill",
    "seendate": "20260106T170000Z",
    "socialimage": "https://www.europeanpharmaceuticalreview.com/wp-content/uploads/shutterstock_2324314165.jpg",
    "domain": "europeanpharmaceuticalreview.com",
    "language": "English",
    "sourcecountry": "United Kingdom"
  }
}